Form 8-K - Current report:
SEC Accession No. 0001213900-25-056911
Filing Date
2025-06-24
Accepted
2025-06-24 08:02:11
Documents
15
Period of Report
2025-06-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0246590-8k_ostherap.htm   iXBRL 8-K 46666
2 FORM OF NEW WARRANT ea024659001ex4-1_ostherap.htm EX-4.1 123642
3 FORM OF INDUCEMENT OFFER LETTER ea024659001ex10-1_ostherap.htm EX-10.1 52581
4 PRESS RELEASE ISSUED BY OS THERAPIES INCORPORATED ON JUNE 23, 2025 ea024659001ex99-1_ostherap.htm EX-99.1 14214
  Complete submission text file 0001213900-25-056911.txt   462694

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE ostx-20250623.xsd EX-101.SCH 3023
6 XBRL LABEL FILE ostx-20250623_lab.xml EX-101.LAB 34239
7 XBRL PRESENTATION FILE ostx-20250623_pre.xml EX-101.PRE 22364
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0246590-8k_ostherap_htm.xml XML 3811
Mailing Address 15825 SHADY GROVE ROAD SUITE 135 ROCKVILLE MD 20850
Business Address 15825 SHADY GROVE ROAD SUITE 135 ROCKVILLE MD 20850 410-297-7793
OS Therapies Inc (Filer) CIK: 0001795091 (see all company filings)

EIN.: 825118368 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42195 | Film No.: 251066711
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)